Use of esmolol after failure of standard cardiopulmonary resuscitation to treat patients with refractory ventricular fibrillation

Resuscitation

Volumn 85, Issue 10, 2014, Pages 1337-1341

  Driver, Brian E ^a   Debaty, Guillaume ^a,b,c   Plummer, David W ^a   Smith, Stephen W ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VERIMAG   (France)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Defibrillation

Indexed keywords

ADRENALIN; AMIODARONE; BICARBONATE; ESMOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PROPANOLAMINE DERIVATIVE;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEFIBRILLATION; DRUG MEGADOSE; EMERGENCY WARD; FEMALE; HEART CATHETERIZATION; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MALE; OUT OF HOSPITAL CARDIAC ARREST; OUTCOME ASSESSMENT; RESUSCITATION; RETROSPECTIVE STUDY; RETURN OF SPONTANEOUS CIRCULATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT FAILURE; COMPLICATION; EVALUATION STUDY; HEART ARREST; MIDDLE AGED; VENTRICULAR FIBRILLATION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; CARDIOPULMONARY RESUSCITATION; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VENTRICULAR FIBRILLATION;

EID: 84907694998     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2014.06.032     Document Type: Article

References (18)

1. Gao D., Sapp J.L. Electrical storm: definitions, clinical importance, and treatment. Curr Opin Cardiol 2013, 28:72-79.
2. Neumar R.W., Otto C.W., Link M.S., et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010, 122:S729-S767.
3. Eifling M., Razavi M., Massumi A. The evaluation and management of electrical storm. Tex Heart Inst J 2011, 38:111-121.
4. Hassan T.B., Jagger C., Barnett D.B. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J 2002, 19:57-62.
5. Bassiakou E., Xanthos T., Papadimitriou L. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. Eur J Pharmacol 2009, 616:1-6.
6. de Oliveira F.C., Feitosa-Filho G.S., Ritt L.E. Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation 2012, 83:674-683.
7. Bourque D., Daoust R., Huard V., Charneux M. beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation?. Resuscitation 2007, 75:434-444.
8. Miwa Y., Ikeda T., Mera H., et al. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 2010, 74:856-863.
9. Nademanee K., Taylor R., Bailey W.E., Rieders D.E., Kosar E.M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000, 102:742-747.
10. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005, 366:1622-1632.
11. Jacobs I., Nadkarni V., Bahr J., et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 2004, 110:3385-3397.
12. Skogvoll E., Eftestøl T., Gundersen K., et al. Dynamics and state transitions during resuscitation in out-of-hospital cardiac arrest. Resuscitation 2008, 78:30-37.
13. Metzger A.K., Herman M., McKnite S., Tang W., Yannopoulos D. Improved cerebral perfusion pressures and 24-hr neurological survival in a porcine model of cardiac arrest with active compression-decompression cardiopulmonary resuscitation and augmentation of negative intrathoracic pressure. Crit Care Med 2012, 40:1851-1856.
14. Aufderheide T.P., Frascone R.J., Wayne M.A., et al. Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial. Lancet 2011, 377:301-311.
15. Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). 3. Advanced life support. J Am Med Assoc 1974, 227(Suppl.):852-860.
16. Jingjun L., Yan Z., Weijie Dongdong Z., Guosheng L., Mingwei B. Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model. Resuscitation 2009, 80:1052-1059.
17. Zhang Q., Li C. Combination of epinephrine with esmolol attenuates post-resuscitation myocardial dysfunction in a porcine model of cardiac arrest. PLoS ONE 2013, 8:e82677.
18. Morelli A., Ertmer C., Westphal M., et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. J Am Med Assoc 2013, 310:1683-1691.